Literature DB >> 10323776

Fish intake, independent of apo(a) size, accounts for lower plasma lipoprotein(a) levels in Bantu fishermen of Tanzania: The Lugalawa Study.

S M Marcovina1, H Kennedy, G Bittolo Bon, G Cazzolato, C Galli, E Casiglia, M Puato, P Pauletto.   

Abstract

Plasma lipoprotein(a) [Lp(a)] levels are largely genetically determined by sequences linked to the gene encoding apolipoprotein(a) [apo(a)], the distinct protein component of Lp(a). Apo(a) is highly polymorphic in length due to variation in the numbers of a sequence encoding the apo(a) kringle 4 domain, and plasma levels of Lp(a) are inversely correlated with apo(a) size. In 2 racially homogeneous Bantu populations from Tanzania differing in their dietary habits, we found that median plasma levels of Lp(a) were 48% lower in those living on a fish diet than in those living on a vegetarian diet. Considering the relationship between apo(a) size and Lp(a) plasma concentration, we have extensively evaluated apo(a) isoform distribution in the 2 populations to determine the impact of apo(a) size in the determination of Lp(a) values. The majority of individuals (82% of the fishermen and 80% of the vegetarians) had 2 expressed apo(a) alleles. Additionally, the fishermen had a high frequency of large apo(a) isoforms, whereas a higher frequency of small isoforms was found in the vegetarians. When subjects from the 2 groups were matched for apo(a) phenotype, the median Lp(a) value was 40% lower in Bantus on the fish diet than in those on the vegetarian diet. A significant inverse relationship was also found between plasma n-3 polyunsaturated fatty acids and Lp(a) levels (r=-0.24, P=0.01). The results of this study are consistent with the concept that a diet rich in n-3 polyunsaturated fatty acids, and not genetic differences, is responsible for the lower plasma levels of Lp(a) in the fish-eating Bantus and strongly suggest that a sustained fish-based diet is able to lower plasma levels of Lp(a).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323776     DOI: 10.1161/01.atv.19.5.1250

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.

Authors:  I Shai; M B Schulze; J E Manson; M J Stampfer; N Rifai; F B Hu
Journal:  Diabetologia       Date:  2005-06-22       Impact factor: 10.122

2.  Elevated Lipoprotein (a) and Risk of Poor Functional Outcome in Chinese Patients with Ischemic Stroke and Type 2 Diabetes.

Authors:  Haoliang Wang; Jun Zhao; Yongkun Gui; Haiqing Yan; Zhixin Yan; Ping Zhang; Li Liu; Li Chang; Jianlong Zhang
Journal:  Neurotox Res       Date:  2017-12-20       Impact factor: 3.911

Review 3.  Effects of fish oils and fish on cardiovascular disease.

Authors:  P Nestel
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

Review 4.  Functional foods and cardiovascular disease.

Authors:  C M Hasler; S Kundrat; D Wool
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

Review 5.  The role of non-LDL:non-HDL particles in atherosclerosis.

Authors:  Jere P Segrest
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

6.  Lipoprotein(a): biology and clinical importance.

Authors:  Sally P A McCormick
Journal:  Clin Biochem Rev       Date:  2004-02

7.  High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans.

Authors:  Erdembileg Anuurad; Jill Rubin; Alan Chiem; Russell P Tracy; Thomas A Pearson; Lars Berglund
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

8.  Dietary determinants of serum total cholesterol among middle-aged and older adults: a population-based cross-sectional study in Dar es Salaam, Tanzania.

Authors:  Sujay S Kakarmath; Rachel M Zack; Germana H Leyna; Saman Fahimi; Enju Liu; Wafaie W Fawzi; Zohra Lukmanji; Japhet Killewo; Frank Sacks; Goodarz Danaei
Journal:  BMJ Open       Date:  2017-06-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.